BR112013008834A2 - produtos mastigáveis macios não à base de amido - Google Patents

produtos mastigáveis macios não à base de amido

Info

Publication number
BR112013008834A2
BR112013008834A2 BR112013008834A BR112013008834A BR112013008834A2 BR 112013008834 A2 BR112013008834 A2 BR 112013008834A2 BR 112013008834 A BR112013008834 A BR 112013008834A BR 112013008834 A BR112013008834 A BR 112013008834A BR 112013008834 A2 BR112013008834 A2 BR 112013008834A2
Authority
BR
Brazil
Prior art keywords
soft chewable
products
starch
chewable products
starch soft
Prior art date
Application number
BR112013008834A
Other languages
English (en)
Other versions
BR112013008834B1 (pt
Inventor
Hans-Jürgen Hamann
Kanikanti Venkata-Ran-Garao
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of BR112013008834A2 publication Critical patent/BR112013008834A2/pt
Publication of BR112013008834B1 publication Critical patent/BR112013008834B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)

Abstract

produtos mastigáveis macios não à base de amido. a presente invenção geralmente se refere a produtos mastigáveis macios, especialmente adequados para administrar ingredientes ativos a animais e processos para a preparação dos mesmos. em várias modalidades, o produto mastigável macio compreende uma quantidade farmaceuticamente eficaz de pelo menos um ingrediente ativo, um agente aromatizante, um desintegrante, um umectante, um antioxidante, um conservante, e água. de acordo com modalidades preferidas, o produto mastigável macio está essencialmente livre de amido, óleo, glicóis, ceras, e produtos de soja.
BR112013008834-6A 2010-10-12 2011-10-11 Produto mastigável macio e seu processo de preparação BR112013008834B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39215010P 2010-10-12 2010-10-12
US61/392,150 2010-10-12
PCT/EP2011/067699 WO2012049156A1 (en) 2010-10-12 2011-10-11 Non-starch based soft chewables

Publications (2)

Publication Number Publication Date
BR112013008834A2 true BR112013008834A2 (pt) 2016-06-28
BR112013008834B1 BR112013008834B1 (pt) 2021-08-03

Family

ID=45065865

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013008834-6A BR112013008834B1 (pt) 2010-10-12 2011-10-11 Produto mastigável macio e seu processo de preparação

Country Status (11)

Country Link
US (1) US9744127B2 (pt)
EP (1) EP2627314B1 (pt)
JP (2) JP2013539772A (pt)
CN (1) CN103200930A (pt)
AU (1) AU2011315555B2 (pt)
BR (1) BR112013008834B1 (pt)
CA (1) CA2814082A1 (pt)
ES (1) ES2806256T3 (pt)
MX (1) MX2013003684A (pt)
RU (1) RU2627420C2 (pt)
WO (1) WO2012049156A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
JP6290081B2 (ja) 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
PL232463B1 (pl) 2012-02-06 2019-06-28 Merial Inc Miękka, nadająca się do żucia kompozycja weterynaryjna do leczenia i/lub zapobiegania infekcji lub inwazji pasożytniczej u zwierzęcia oraz jej zastosowanie
JP6088637B2 (ja) 2012-04-04 2017-03-01 インターベット インターナショナル ベー． フェー． イソオキサゾリン化合物のための固形経口医薬組成物
AU2013361760B2 (en) * 2012-12-19 2018-07-05 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
WO2017087941A1 (en) 2015-11-20 2017-05-26 Isp Investments Llc Proliferous polymers comprising lactamic moieties
AU2017262630A1 (en) * 2016-05-12 2018-11-22 Bayer Animal Health Gmbh Method for the production of molded bodies for administration to animals
CN110996920A (zh) * 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
CA3072123A1 (en) 2017-08-17 2019-02-21 Ceva Sante Animale Oral compositions and the preparation methods thereof
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
EP3878436A1 (en) 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
EP4146011A1 (en) * 2020-05-06 2023-03-15 Mars Incorporated Palatable support compositions for administration of medicinal products
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (pt) 1985-09-18 1990-05-05 Pfizer
JPH0479844A (ja) * 1990-07-20 1992-03-13 Ajinomoto Co Inc 反芻動物用飼料添加剤
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
NZ538139A (en) 2002-08-13 2008-03-28 Intervet Int Bv Compositions and process for delivering an additive
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20060233873A1 (en) 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
AU2004251439B2 (en) * 2003-06-25 2008-09-11 Novartis Ag Tablet comprising fluvastatin and carmellose calcium
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) * 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
WO2008030469A2 (en) * 2006-09-07 2008-03-13 Merial Limited Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
AU2008247327B2 (en) * 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process

Also Published As

Publication number Publication date
JP2016175936A (ja) 2016-10-06
JP6200548B2 (ja) 2017-09-20
EP2627314A1 (en) 2013-08-21
BR112013008834B1 (pt) 2021-08-03
US20130197006A1 (en) 2013-08-01
WO2012049156A1 (en) 2012-04-19
MX2013003684A (es) 2013-05-31
EP2627314B1 (en) 2020-05-06
ES2806256T3 (es) 2021-02-17
AU2011315555A1 (en) 2013-05-02
RU2013120907A (ru) 2014-11-20
AU2011315555B2 (en) 2016-03-10
RU2627420C2 (ru) 2017-08-08
CA2814082A1 (en) 2012-04-19
CN103200930A (zh) 2013-07-10
US9744127B2 (en) 2017-08-29
JP2013539772A (ja) 2013-10-28

Similar Documents

Publication Publication Date Title
BR112013008834A2 (pt) produtos mastigáveis macios não à base de amido
NZ734516A (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n’-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
BR112014028841A2 (pt) processo para preparação de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metil-piperazin-l-il)-2-(tetra-hidro-piran-4-ilamino)-benzamida
NZ631112A (en) Crystalline bromodomain inhibitors
NZ631100A (en) Soft chewable pharmaceutical products
BR112012009487A2 (pt) formulações de espessante estáveis
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
WO2014060638A8 (en) A veterinary method of alleviating noise aversion
AR090874A1 (es) Formulacion
NI201900063A (es) Amidas aromáticas de ácido carboxílico
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
WO2011136573A3 (ko) 비만 치료 및 항산화 활성을 갖는 효모 가수분해물
CY1116274T1 (el) Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας
BR112012021445B8 (pt) formulação farmacêutica ou neutracêutica, e uso de um agente promotor de biodisponibilidade
UY31059A1 (es) Formulaciones de aminoacido n-halogenado
NZ708821A (en) Lfa-1 inhibitor formulations
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
JP2006089487A5 (pt)
WO2009150257A3 (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
WO2008075333A3 (en) Edible compositions for preventing hair loss
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/10/2011, OBSERVADAS AS CONDICOES LEGAIS.